Document Detail

Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome?
MedLine Citation:
PMID:  19438773     Owner:  NLM     Status:  MEDLINE    
Coronary revascularization methods continue to be refined, and the emergence of the drug-eluting stent (DES) has especially changed clinical practice related to ischemic heart disease. For chronic hemodialysis (HD) patients, however, the impact of DES on clinical outcome is yet to be determined. Forty-six consecutive chronic HD patients who underwent myocardial revascularization in our institute were retrospectively reviewed. Twenty-eight patients underwent coronary artery bypass surgery (CABG) and 18 patients underwent percutaneous coronary artery intervention (PCI). Patient characteristics were similar between the two groups. In the CABG group, bilateral internal thoracic artery (ITA) bypass grafting was performed in 27 patients and off-pump CABG was performed in 20 patients. In the PCI group, a DES was used in 12 patients. The number of coronary vessels treated per patient was higher in the CABG group (CABG: 4.25 +/- 1.32 vs. PCI: 1.44 +/- 0.78; p < 0.001). Two-year survival rates were similar between the two groups (CABG: 94.1% vs. PCI: 73.9%; p = 0.41), but major adverse cardiac event-free survival (CABG: 85.9% vs. PCI: 37.1%; p = 0.001) and angina-free survival (CABG: 84.9% vs. PCI: 28.9%; p < 0.001) rates were significantly higher in the CABG group. The one-year patency rate for the CABG grafts was 93.3% (left ITA: 100%, right ITA: 84.6%, sapenous vein: 90.9%, gastro-epiploic artery: 100%), and six-month restenosis rate for PCI was 57.1% (balloon angio-plasty: 75%, bare metal stent 40%, DES: 58.3%). Even in the era of DES, clinical results favored CABG. The difference in clinical results is due to the sustainability of successful revascularization.
Susumu Manabe; Tomoki Shimokawa; Toshihiro Fukui; Ken-u Fumimoto; Naomi Ozawa; Hiroshi Seki; Shuichiro Takanashi
Related Documents :
14663613 - Atorvastatin stent coating does not reduce neointimal proliferation after coronary sten...
16197833 - Preliminary evidence supporting the safety of drug-eluting stents in neurovascular dise...
16526593 - The deep axillary artery.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Journal of cardiac surgery     Volume:  24     ISSN:  1540-8191     ISO Abbreviation:  J Card Surg     Publication Date:    2009 May-Jun
Date Detail:
Created Date:  2009-05-14     Completed Date:  2009-08-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8908809     Medline TA:  J Card Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  234-9     Citation Subset:  IM    
Department of Cardiovascular Surgery, Sakakibara Heart Institute, Tokyo, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Transluminal, Percutaneous Coronary / methods*
Coronary Artery Bypass / methods*
Coronary Artery Disease / complications,  mortality,  therapy*
Disease-Free Survival
Drug-Eluting Stents*
Follow-Up Studies
Japan / epidemiology
Kidney Failure, Chronic / complications,  mortality,  therapy*
Middle Aged
Renal Dialysis / methods*
Retrospective Studies
Survival Rate
Time Factors
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Evaluation of the chondral modeling theory using fe-simulation and numeric shape optimization.
Next Document:  Elective hypothermic circulatory arrest to address aortic pathology is safe for the elderly.